Corticosteroid induced pancreatitis

Use of QVAR with a spacer device in children less than 5 years of age is not recommended. In vitro dose characterization studies were performed with QVAR 40 mcg/actuation with the OptiChamber and AeroChamber Plus ® spacer utilizing inspiratory flows representative of children under 5 years old. These studies indicated that the amount of medication delivered through the spacing device decreased rapidly with increasing wait times of 5 to 10 seconds as shown in Table 2. If QVAR is used with a spacer device, it is important to inhale immediately.

Corticosteroid induced pancreatitis

corticosteroid induced pancreatitis

Media:

corticosteroid induced pancreatitiscorticosteroid induced pancreatitiscorticosteroid induced pancreatitiscorticosteroid induced pancreatitiscorticosteroid induced pancreatitis